0,996  0,001  Monophenol monooxygenase inhibitor
0,986  0,002  Chemoprotective
0,980  0,002  Mutagenic
0,976  0,001  Chemopreventive
0,976  0,001  Xanthine oxidase inhibitor
0,975  0,001  NOS2 expression inhibitor
0,971  0,001  Proliferative diseases treatment
0,971  0,002  Genotoxic
0,960  0,001  Antimutagenic
0,951  0,001  Antihypoxic
0,948  0,005  Alpha-glucosidase inhibitor
0,937  0,003  Antioxidant
0,930  0,003  Carcinogenic
0,925  0,004  Transcription factor NF kappa B inhibitor
0,921  0,004  TNF expression inhibitor
0,917  0,002  Caspase 9 stimulant
0,905  0,003  Cardioprotectant
0,903  0,003  Antihypercholesterolemic
0,899  0,003  Cytostatic
0,896  0,002  UGT1A9 substrate
0,895  0,003  Radioprotector
0,887  0,003  Free radical scavenger
0,889  0,005  Antiinflammatory
0,888  0,007  Apoptosis agonist
0,880  0,003  Vasodilator, coronary
0,877  0,001  Amylase inhibitor
0,879  0,003  DNA damaging
0,866  0,001  Antihemorrhagic
0,858  0,005  Cyclophilin D inhibitor
0,858  0,005  Antidiabetic
0,838  0,002  UGT1A1 substrate
0,838  0,004  Antithrombotic
0,836  0,007  Teratogen
0,830  0,007  Embryotoxic
0,803  0,004  Angiogenesis stimulant
0,803  0,004  Hypoglycemic
0,790  0,004  Nitric oxide antagonist
0,787  0,002  Melanin inhibitor
0,789  0,004  Antibacterial
0,782  0,001  Nitric-oxide synthase stimulant
0,778  0,004  AR expression inhibitor
0,771  0,004  NOS3 expression inhibitor
0,756  0,005  5 Hydroxytryptamine release stimulant
0,753  0,004  Apoptosis antagonist
0,751  0,005  Caspase 3 stimulant
0,743  0,004  Skin whitener
0,746  0,009  Antileukemic
0,734  0,002  Carbonic anhydrase III inhibitor
0,734  0,004  Antihypertriglyceridemic
0,729  0,004  Vascular (periferal) disease treatment
0,722  0,005  Hepatic disorders treatment
0,713  0,003  NOS3 expression enhancer
0,714  0,005  Antiamyloidogenic
0,712  0,006  Cytotoxic
0,711  0,005  Antiparasitic
0,707  0,004  Hepatoprotectant
0,710  0,017  Antineoplastic (lung cancer)
0,693  0,005  UDP-glucuronosyltransferase substrate
0,690  0,005  Tumour necrosis factor alpha release inhibitor
0,686  0,004  Antihelmintic
0,684  0,002  AMP-activated protein kinase stimulant
0,685  0,004  Sulfotransferase substrate
0,684  0,007  Spasmolytic
0,674  0,003  Hemostatic
0,674  0,010  Immunostimulant
0,656  0,003  Carbonic anhydrase VI inhibitor
0,675  0,024  Antineoplastic (breast cancer)
0,649  0,003  Antitussive
0,659  0,018  Antineoplastic (colorectal cancer)
0,639  0,003  Cystathionine beta-synthase inhibitor
0,633  0,004  Antineoplastic (osteosarcoma)
0,635  0,007  UGT1A6 substrate
0,631  0,008  Histamine release inhibitor
0,625  0,007  Antipyretic
0,637  0,025  CYP3A4 substrate
0,615  0,005  RNA-directed DNA polymerase inhibitor
0,628  0,019  Antineoplastic (colon cancer)
0,620  0,016  Prostate cancer treatment
0,604  0,003  Protein kinase stimulant
0,602  0,004  Alkylator
0,598  0,011  Antipruritic, allergic
0,591  0,004  Non-steroidal antiinflammatory agent
0,591  0,009  Antiprotozoal (Leishmania)
0,585  0,004  Mediator release inhibitor
0,585  0,004  ICAM1 expression inhibitor
0,582  0,004  Antihypotensive
0,579  0,010  Antifungal
0,572  0,003  Carbonic anhydrase XIII inhibitor
0,571  0,004  Antidote
0,575  0,015  Antineoplastic (cervical cancer)
0,565  0,008  Vasodilator
0,560  0,005  Antineoplastic (sarcoma)
0,555  0,005  Topoisomerase II inhibitor
0,566  0,018  CYP2C19 substrate
0,572  0,024  CYP2C9 substrate
0,550  0,004  VCAM1 expression inhibitor
0,549  0,004  Lipid peroxidase inhibitor
0,561  0,017  Antineoplastic (melanoma)
0,555  0,020  Antineoplastic (ovarian cancer)
0,535  0,003  Expectorant
0,546  0,022  Immunosuppressant
0,534  0,011  Amyloid beta aggregation inhibitor
0,520  0,008  UGT2B4 substrate
0,520  0,010  Antineoplastic (lymphoma)
0,530  0,025  Respiratory analeptic
0,517  0,020  Antineoplastic (pancreatic cancer)
0,512  0,017  Antineoplastic (glioma)
0,530  0,039  Alzheimer's disease treatment
0,511  0,022  Immunomodulator
0,496  0,009  Antineoplastic (liver cancer)
0,486  0,005  Platelet adhesion inhibitor
0,491  0,012  Antidiabetic symptomatic
0,472  0,003  Cyclooxygenase 3 inhibitor
0,492  0,025  Ulceration
0,469  0,003  Antihelmintic (Trematoda)
0,487  0,023  Sensitization
0,461  0,004  Beta glucuronidase inhibitor
0,459  0,010  Antiviral (Herpes)
0,450  0,014  Myocardial infarction treatment
0,460  0,027  Antiischemic
0,457  0,026  Antiosteoporotic
0,450  0,020  Antineoplastic (glioblastoma multiforme)
0,451  0,024  Antineoplastic (multiple myeloma)
0,462  0,037  Stroke treatment
0,428  0,006  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,425  0,004  Topoisomerase II alpha inhibitor
0,434  0,014  Antineoplastic (small cell lung cancer)
0,427  0,008  Antiviral (Influenza)
0,447  0,028  Antineoplastic (brain cancer)
0,419  0,003  DNA repair enzyme inhibitor
0,419  0,005  Topoisomerase I inhibitor
0,429  0,017  Antineoplastic enhancer
0,449  0,037  Bone diseases treatment
0,423  0,021  Radiosensitizer
0,427  0,026  Antidiabetic (type 2)
0,467  0,066  Antiarthritic
0,419  0,019  DNA synthesis inhibitor
0,406  0,008  UGT2B15 substrate
0,401  0,005  Aldose reductase substrate
0,422  0,025  Hypoxia-inducible factor 1 alpha inhibitor
0,399  0,005  Antifungal enhancer
0,408  0,015  Cyclic AMP phosphodiesterase inhibitor
0,396  0,005  Dementia treatment
0,401  0,011  Antineoplastic (squamous cell carcinoma)
0,393  0,005  Vascular dementia treatment
0,391  0,003  Selectin antagonist
0,391  0,005  Antineoplastic antibiotic
0,404  0,026  Interleukin 2 agonist
0,411  0,037  CYP1A2 substrate
0,366  0,008  Neurotrophic factor enhancer
0,361  0,005  Interleukin 4 antagonist
0,389  0,034  Antineoplastic (non-small cell lung cancer)
0,393  0,039  Analeptic
0,349  0,004  Interleukin 12 antagonist
0,367  0,026  Antiulcerative
0,352  0,011  Antiviral (Influenza A)
0,368  0,031  Antineoplastic (renal cancer)
0,337  0,008  Psychosexual dysfunction treatment
0,370  0,044  CTGF expression inhibitor
0,334  0,009  Insulin secretagoues
0,369  0,047  Lipoprotein disorders treatment
0,333  0,015  Peptidyltransferase inhibitor
0,336  0,026  Septic shock treatment
0,366  0,058  Cholesterol antagonist
0,323  0,015  Antineoplastic (gastric cancer)
0,312  0,004  Antiviral (Influenza B)
0,312  0,004  Histone deacetylase stimulant
0,312  0,004  Histone deacetylase SIRT1 stimulant
0,311  0,004  Aldose reductase inhibitor
0,310  0,003  Carbonic anhydrase XIV inhibitor
0,324  0,019  Antineoplastic (carcinoma)
0,322  0,017  Interferon gamma antagonist
0,311  0,010  Hexokinase inhibitor
0,323  0,030  Wound healing agent
0,371  0,079  CYP2C19 inhibitor
0,296  0,006  ATPase inhibitor
0,298  0,010  Cell wall synthesis inhibitor
0,368  0,083  Antiprotozoal
0,303  0,021  Antipruritic, non-allergic
0,292  0,011  Carcinogenic, group 1
0,286  0,005  Antiviral (Ebola)
0,280  0,005  Alcohol dehydrogenase inhibitor
0,282  0,008  Antibiotic
0,313  0,042  Interleukin agonist
0,275  0,005  Photosensitizer
0,295  0,029  DNA methylase inhibitor
0,287  0,026  Thrombolytic
0,275  0,016  NADPH oxidase inhibitor
0,289  0,031  P-glycoprotein inhibitor
0,275  0,017  Acute respiratory distress syndrome (ARDS) treatment
0,276  0,020  Liver fibrosis treatment
0,360  0,107  5 Hydroxytryptamine release inhibitor
0,261  0,010  Mannose-6-phosphate isomerase inhibitor
0,319  0,068  Antimycobacterial
0,296  0,046  Antineoplastic (bladder cancer)
0,253  0,004  Chronic obstructive bronchitis treatment
0,281  0,034  DNA methyltransferase I inhibitor
0,252  0,005  Transcription factor NF kappa B stimulant
0,243  0,003  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,260  0,021  Interleukin 6 antagonist
0,240  0,006  Gastritis treatment
0,282  0,051  Antineoplastic (lymphocytic leukemia)
0,258  0,031  Sepsis treatment
0,232  0,007  Carbonic anhydrase XII inhibitor
0,240  0,016  Gout treatment
0,239  0,016  Cell adhesion inhibitor
0,224  0,003  Antibiotic Glycopeptide-like
0,227  0,009  Uric acid excretion stimulant
0,237  0,023  Alkaline phosphatase inhibitor
0,217  0,004  Phosphodiesterase 6D inhibitor
0,241  0,032  Diabetic nephropathy treatment
0,239  0,034  UGT1A3 substrate
0,269  0,064  Platelet antagonist
0,238  0,034  Protein-tyrosine phosphatase inhibitor
0,227  0,025  Antidiarrheal
0,209  0,017  UDP-glucose 4-epimerase inhibitor
0,266  0,075  CYP1A2 inhibitor
0,213  0,022  DNA intercalator
0,307  0,117  Atherosclerosis treatment
0,286  0,100  Angiogenesis inhibitor
0,208  0,026  DNA polymerase I inhibitor
0,191  0,012  Creatine kinase inhibitor
0,240  0,061  Antiviral (HIV)
0,332  0,155  Antineoplastic (solid tumors)
0,185  0,009  Toll-Like receptor 4 antagonist
0,197  0,021  Antifungal (Cryptococcus)
0,180  0,005  Phosphodiesterase VI inhibitor
0,182  0,010  Thioredoxin inhibitor
0,252  0,081  Antiprotozoal (Trypanosoma)
0,191  0,020  Anticataract
0,183  0,014  Multidrug resistance-associated protein 1 inhibitor
0,172  0,004  Fatty acid synthase inhibitor
0,197  0,030  Protein-tyrosine phosphatase 1B inhibitor
0,182  0,015  Antineoplastic (uterine cancer)
0,194  0,027  Glutathione S-transferase substrate
0,202  0,037  Carcinogenic, group 3
0,217  0,055  UGT2B7 substrate
0,231  0,069  Interleukin antagonist
0,165  0,004  Alpha-mannosidase inhibitor
0,187  0,026  Retinoprotector
0,191  0,030  Aldehyde dehydrogenase inhibitor
0,192  0,034  SULT1A3 substrate
0,161  0,004  Na+ K+ transporting ATPase inhibitor
0,197  0,042  Antineoplastic (bone cancer)
0,153  0,004  Mannosidase inhibitor
0,251  0,103  Metabolic disease treatment
0,170  0,025  Choleretic
0,156  0,011  Estrogen agonist
0,146  0,002  Sodium/glucose cotransporter inhibitor
0,190  0,046  Cyclooxygenase inhibitor
0,164  0,023  Heat shock protein 70 antagonist
0,222  0,081  Hypolipemic
0,148  0,008  ATPase (Vacuolar H+) inhibitor
0,149  0,010  T cell inhibitor
0,150  0,013  HIV-1 integrase (3'-Processing) inhibitor
0,153  0,017  NADH dehydrogenase inhibitor
0,257  0,122  Vasodilator, peripheral
0,144  0,011  Lipase inhibitor
0,139  0,007  Carbonic anhydrase VII inhibitor
0,132  0,002  Sodium/glucose cotransporter 2 inhibitor
0,247  0,118  CYP3A4 inhibitor
0,171  0,042  Cyclooxygenase 2 inhibitor
0,138  0,010  Antiviral (Dengue virus)
0,239  0,112  CYP2D6 substrate
0,195  0,068  Growth factor agonist
0,153  0,028  Antineoplastic, alkylator
0,169  0,044  Acetylcholinesterase inhibitor
0,139  0,014  HIV-1 integrase (Strand Transfer) inhibitor
0,171  0,046  CF transmembrane conductance regulator agonist
0,127  0,003  Arginase inhibitor
0,139  0,019  SULT1E1 substrate
0,154  0,034  Chelator
0,143  0,026  Estrogen antagonist
0,118  0,002  Sodium/glucose cotransporter 1 inhibitor
0,153  0,037  Carcinogenic, group 2B
0,135  0,021  Phosphofructokinase-1 inhibitor
0,124  0,011  Neuraminidase (influenza) inhibitor
0,161  0,051  Cyclooxygenase 1 inhibitor
0,150  0,040  Beta amyloid protein antagonist
0,112  0,003  Antibiotic Aminoglycoside-like
0,142  0,035  HDL-cholesterol increasing
0,118  0,011  Xanthine dehydrogenase inhibitor
0,109  0,003  Cholesterol absorption inhibitor
0,157  0,051  Alpha-N-acetylglucosaminidase inhibitor
0,150  0,046  Antiviral (Hepatitis B)
0,113  0,010  Protein 50S ribosomal subunit inhibitor
0,111  0,009  Antimycoplasmal
0,119  0,019  Glycine receptor antagonist
0,155  0,055  Adenylate cyclase stimulant
0,139  0,039  Mucolytic
0,110  0,012  Neuraminidase inhibitor
0,097  0,003  Protein 30S ribosomal subunit inhibitor
0,123  0,030  Antispirochetal
0,105  0,015  Maillard reaction inhibitor
0,171  0,082  Antirickettsial
0,114  0,026  Glutamate release inhibitor
0,114  0,028  Interleukin 5 antagonist
0,157  0,071  Diuretic
0,153  0,069  Hearing loss treatment
0,117  0,034  Actinic keratosis treatment
0,089  0,006  Glucose-6-phosphate isomerase inhibitor
0,170  0,088  Antiviral (Hepatitis)
0,106  0,025  CDC25A inhibitor
0,082  0,006  Heparanase inhibitor
0,130  0,059  Growth stimulant
0,110  0,039  Triose-phosphate isomerase inhibitor
0,119  0,049  UGT2B1 substrate
0,090  0,019  Postmenopausal disorders treatment
0,104  0,035  NAD(P)H dehydrogenase (quinone) inhibitor
0,238  0,169  Antineoplastic (non-Hodgkin's lymphoma)
0,108  0,041  Carcinogenic, group 2A
0,113  0,046  Sphingomyelinase inhibitor
0,135  0,069  Antiacne
0,077  0,012  Glucose-6-phosphate translocase inhibitor
0,083  0,020  Nitric oxide donor
0,110  0,047  Estrogen receptor beta antagonist
0,150  0,090  Muscular dystrophy treatment
0,142  0,082  Peroxidase inhibitor
0,087  0,029  Antitreponemal
0,167  0,111  Insulin sensitizer
0,116  0,066  Microtubule formation inhibitor
0,093  0,046  Antiviral (Trachoma)
0,072  0,031  Antidote, heavy metal
0,087  0,046  Thioredoxin reductase inhibitor
0,109  0,068  SULT1A1 substrate
0,057  0,018  Estrogen receptor beta agonist
0,139  0,099  Antihelmintic (Nematodes)
0,122  0,083  Contraceptive
0,091  0,058  Falcipain 2 inhibitor
0,093  0,060  Falcipain inhibitor
0,056  0,024  Equilibrative nucleoside transport protein inhibitor
0,033  0,003  Telomerase stimulant
0,051  0,022  Neuraminidase (Influenza A) inhibitor
0,177  0,149  Antituberculosic
0,031  0,003  Antibiotic Anthracycline-like
0,033  0,009  1,3-Beta-glucan synthase inhibitor
0,117  0,094  Vanilloid 1 agonist
0,070  0,048  HIV-1 integrase inhibitor
0,125  0,105  Anticoagulant
0,029  0,010  Vanilloid 2 agonist
0,134  0,116  Diabetic retinopathy treatment
0,215  0,197  Antineoplastic (endocrine cancer)
0,062  0,045  Carbonic anhydrase inhibitor
0,063  0,047  CDC25B inhibitor
0,037  0,022  Estrogen receptor alpha agonist
0,028  0,015  Toll-Like receptor 4 agonist
0,033  0,021  Estrogen-related receptor beta antagonist
0,050  0,042  Carbonic anhydrase IX inhibitor
0,178  0,171  Transcription factor STAT inhibitor
0,072  0,066  Interferon agonist
0,052  0,046  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,046  0,040  Topoisomerase II beta inhibitor
0,055  0,050  Lipocortins synthesis agonist
0,103  0,100  Toll-Like receptor 2 antagonist
0,070  0,068  Narcotic antagonist
0,012  0,011  Antibiotic Macrolide-like
0,126  0,125  Cystic fibrosis treatment
0,021  0,020  Adenosine A1 receptor agonist

